CVS Caremark

Each year, any number of organizations publish lists of America's highest paid CEOs. But the real question is: How many of them can be said to have earned those gigantic pay packages. 24/7 Wall St. dug into the numbers to find out.

Tallying up the flu's effect on our economy is enough to make you sick. Influenza was responsible for 100 million lost work days in 2010, according to a Walgreens study. That's $7 billion in lost wages, and $10 billion in lost productivity. Inspired to get vaccinated this year? We'll point you to the best deal.

CVS Caremark is best known for its drugstore busines. But it's also finding its way into the business of managing prescription-drug insurance claims. After taking some heat in the last few quarters, it is starting to see revenue from some big contracts in this segment.

CVS Caremark and Walgreen are the leading pharmacy chains in the U.S. While both have been aggressively expanding their retail footprints, there has been a gradual decrease in the average size of the newly opened stores. Here's why they're going small, and what it means for their profits.

Not everyone is happy about the mild start to the cold-and-flu season. The nation's drugstore chains, already under pricing pressure from Walmart and each other, would be happier if the rest of us had coughs and sniffles. Here are bull and bear cases for the three big chains. [Video]

Drugstore chain Walgreen is looking to sell its pharmacy-benefits management business and has hired Bank of America to run an auction.

CVS Caremark has agreed to pay $77.6 million in fines for illegally selling a chemical, common in some cold and cough medicines, that ended up being used to make methamphetamine.

Johnson & Johnson, Walgreen and CVS all received letters from the U.S. Food and Drug Administration warning the companies to remove claims that mouthwash helps prevent gum disease. The letters continue U.S. regulators' crackdown on alleged false advertising from retailers and consumer-goods makers.

Earlier this week, CVS Caremark said it will exclude Walgreen from its pharmacy network following a dispute between the two. The decision is risky for both companies, but analysts have appeared more concerned about its impact on Walgreen.

At issue is the Employee Free Choice Act (EFCA), also known as Card Check, a union-backed proposal that would enable workers to join a union if more than 50% of workers at a facility sign membership cards.